AscendiantLogo Better
Contact

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Capital Markets LLC Serves as Financial Advisor on $7,500,000 Registered Direct for Intrusion Inc. (Nasdaq: INTZ)

JUPITER, Florida – January 31, 2025 — Ascendiant Capital Markets LLC (“Ascendiant”) announced today the closing of a $7,500,000 Registered Direct financing for Intrusion Inc. (Nasdaq: INTZ).

Ascendiant served as Financial Advisor on the transaction. To view the announcement, click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

Newsletter Form (#2)

See other recent news

February 18, 2025
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $3,371,000 At-the-Market (ATM) Offering for Society Pass Incorporated (Nasdaq: SOPA)
January 31, 2025
Ascendiant Capital Markets LLC Serves as Financial Advisor on $7,500,000 Registered Direct for Intrusion Inc. (Nasdaq: INTZ)
January 23, 2025
Ascendiant Hosts IGC Pharma, Inc. (NYSE American: IGC) Fireside Chat 2025
January 10, 2025
Ascendiant Capital Markets LLC to Attend JPM Week in San Francisco, January 13-15, 2025
October 28, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $21,340,000 At-the-Market (ATM) Offering for Giftify, Inc. (Nasdaq: GIFT)
October 10, 2024
Ascendiant Initiates Equity Research Coverage on GRI Bio, Inc. (Nasdaq: GRI)
October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)
September 30, 2024
Ascendiant Capital Markets LLC announced today the filing of a $1,075,000 At-the-Market (ATM) Offering for Aclarion, Inc. (Nasdaq: ACON) of Broomfield, Colorado
September 16, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $2,600,000 At-the-Market (ATM) Offering for Auddia Inc. (Nasdaq: AUUD)
September 12, 2024
Ascendiant Serves as Financial Advisor on $2,510,000 Private Placement for Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS)
September 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) Increased to $50,000,000
September 3, 2024
Ascendiant Completes 23rd Year in Business, Moves Forward Into Year 24

Big enough to deliver

but small enough to care

get in touch
Ascendiant LogoWhite

Services

Resources

Quicklinks

Contact

  • Ascendiant Capital Markets, LLC
Linkedin-in

Important Legal Information & Disclosures

©2025 Ascendiant Capital Markets, LLC, All Rights Reserved.

Member FINRA & SIPC.

a man wearing a suit and tie

Hi there!

How can we help?